| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.24 |
6e-06 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.25 |
2e-05 |
| mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0008 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |